Literature DB >> 2144822

1-(m-chlorophenyl)-biguanide, a potent high affinity 5-HT3 receptor agonist.

G J Kilpatrick1, A Butler, J Burridge, A W Oxford.   

Abstract

1-(m-Chlorophenyl)-biguanide (mCPBG) was examined and compared with three 5-HT3 receptor agonists in three 5-HT3 receptor models. mCPBG inhibited [3H]GR67330 binding to 5-HT3 receptors with high affinity (IC50 1.5 nM). mCPBG depolarized the rat vagus nerve with an EC50 one tenth of that for 5-HT (0.05 vs. 0.46 microM); the maximum depolarization was approximately half that for 5-HT. The mCPBG depolarization was potently blocked by the selective 5-HT3 antagonist, ondansetron (pKB 8.6 +/- 0.1). In anaesthetised cats, mCPBG potently evoked the Bezold-Jarisch reflex which was blocked by low doses of ondansetron (10 micrograms/kg i.v.). It is concluded that mCPBG is a potent, high affinity 5-HT3 receptor agonist.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2144822     DOI: 10.1016/0014-2999(90)90513-6

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  34 in total

1.  Co-expression of the 5-HT3B serotonin receptor subunit alters the biophysics of the 5-HT3 receptor.

Authors:  G Hapfelmeier; C Tredt; R Haseneder; W Zieglgänsberger; B Eisensamer; R Rupprecht; G Rammes
Journal:  Biophys J       Date:  2003-03       Impact factor: 4.033

2.  Characterization of the 5-hydroxytryptamine receptors mediating contraction in the pig isolated intravesical ureter.

Authors:  Medardo Hernández; María Victoria Barahona; Ulf Simonsen; Paz Recio; Luis Rivera; Ana Cristina Martínez; Albino García-Sacristán; Luis M Orensanz; Dolores Prieto
Journal:  Br J Pharmacol       Date:  2003-01       Impact factor: 8.739

3.  The pharmacological characterization of 5-HT3 receptors in three isolated preparations derived from guinea-pig tissues.

Authors:  A Butler; C J Elswood; J Burridge; S J Ireland; K T Bunce; G J Kilpatrick; M B Tyers
Journal:  Br J Pharmacol       Date:  1990-11       Impact factor: 8.739

Review 4.  The non-antiemetic uses of serotonin 5-HT3 receptor antagonists. Clinical pharmacology and therapeutic applications.

Authors:  A J Greenshaw; P H Silverstone
Journal:  Drugs       Date:  1997-01       Impact factor: 9.546

5.  Attenuation of 1-(m-chlorophenyl)-biguanide induced hippocampus-dependent memory impairment by a standardised extract of Bacopa monniera (BESEB CDRI-08).

Authors:  Koilmani Emmanuvel Rajan; Hemant K Singh; Arunagiri Parkavi; Prisila Dulcy Charles
Journal:  Neurochem Res       Date:  2011-07-07       Impact factor: 3.996

6.  Activation of serotonin 3 receptors changes in vivo auditory responses in the mouse inferior colliculus.

Authors:  Alexander Bohorquez; Laura M Hurley
Journal:  Hear Res       Date:  2009-02-21       Impact factor: 3.208

7.  Characterization of 5-HT3 receptors of N1E-115 neuroblastoma cells by use of the influx of the organic cation [14C]-guanidinium.

Authors:  H Bönisch; M Barann; J Graupner; M Göthert
Journal:  Br J Pharmacol       Date:  1993-02       Impact factor: 8.739

Review 8.  5-HT3 receptors.

Authors:  A J Thompson; S C R Lummis
Journal:  Curr Pharm Des       Date:  2006       Impact factor: 3.116

9.  Are there changes in sensitivity to 5-HT3 receptor ligands following chronic diazepam treatment?

Authors:  N Andrews; S E File
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

10.  A coupled array of noncovalent interactions impacts the function of the 5-HT3A serotonin receptor in an agonist-specific way.

Authors:  Timothy F Miles; Kiowa S Bower; Henry A Lester; Dennis A Dougherty
Journal:  ACS Chem Neurosci       Date:  2012-07-20       Impact factor: 4.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.